Kohjin Bio Co., Ltd. (177A) Cash flow
Market cap
¥7B
P/E ratio
20.8x
Kojin Bio manufactures bacterial culture media, antigen test kits, and cell culture products for research institutions, pharmaceutical companies, and medical facilities.
| 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Depreciation & amortization | 179 | 168 | 300 | 361 |
| Cash from operations | 763 | 461 | 824 | 916 |
| Capital expenditures | -203 | -561 | -563 | -862 |
| Cash from investing | 83 | -575 | -577 | -1,091 |
| Payments for dividends | -34 | -42 | -79 | -58 |
| Proceeds from issuance of term debt, net | - | - | 750 | - |
| Repayments of term debt | -662 | -410 | -940 | -150 |
| Cash from financing | -360 | -172 | -1 | 1,376 |
| Free cash flow | ||||
| FCF margin (%) |